This document is an excerpt from the EUR-Lex website
Document 31989L0381
National transposition measures communicated by the Member States concerning:
Richtlinie 89/381/EWG des Rates vom 14. Juni 1989 zur Erweiterung des Anwendungsbereichs der Richtlinien 65/65/EWG und 75/319/EWG zur Angleichung der Rechts- und Verwaltungsvorschriften über Arzneispezialitäten und zur Festlegung besonderer Vorschriften für Arzneimittel aus menschlichem Blut oder Blutplasma
OJ L 181, 28/06/1989, p. 44–46
(ES, DA, DE, EL, EN, FR, IT, NL, PT) This document has been published in a special edition(s)
(FI, SV)
The member states bear sole responsibility for all information on this site provided by them on the transposition of EU law into national law. This does not, however, prejudice the results of the verification by the Commission of the completeness and correctness of the transposition of EU law into national law as formally notified to it by the member states. The collection National transposition measures is updated weekly.
Décision ministérielle numéro D6/OIK/3124 du 11/03/1992. FEK numéro 220 du 02/04/1992 Page 2063
Regeling bloedprodukten, Staatscourant nummer 195 van 12/10/1993 bladzijde 08
Lääkelaki (395/87) 10/04/1987, muutos (1046/93) 26/11/1993
Läkemedelslag, Svensk författningssamling SFS) 1992:859
Läkemedelsförordning, Svensk författningssamling SFS) 1992:1752
The Medicines Act 1968 (Amendment) Regulations 1992. Statutory Instruments number 604 of 1992